Author

Jingdong Chao 1

1 Abbvie Inc., North Chicago, United States

COST-EFFECTIVENESS OF ADALIMUMAB IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS (SUB-ACUTE) IN THE UK

Hongbo Yang, Alistair Curry, Song Wang, MIn A. Yang, Martha Skup, Jingdong Chao, Yanjun Bao

DISCORDANCE BETWEEN PATIENTS AND PHYSICIANS IN LONG-TERM USE OF STEROIDS: RESULTS FROM A PATIENT- AND PHYSICIAN-REPORTED SURVEY

Subrata Ghosh, Jill Petkau, Roopal B Thakkar, Jingdong Chao, Martha Skup, Song Wang, Remo Panaccione, Stefan Schreiber

HOSPITALIZATION RATES IN PATIENTS WITH CROHN’S DISEASE AND DEEP REMISSION: DATA FROM THE 56-WEEK CHARM TRIAL

Jean-Frederic Colombel, Remo Panaccione, Edouard Louis, Mei Yang, Martha Skup, Roopal B Thakkar, Parvez Mulani, Jingdong Chao, William Sandborn

INDIRECT COMPARISON OF ADALIMUMAB AND VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE IN THE UNITED KINGDOM: COST PER RESPONDER/REMITTER ANALYSIS

Yifei Liu, William Reichmann, Song Wang, Dendy Macaulay, Martha Skup, Jingdong Chao, Yanjun Bao

LONG-TERM EFFECTIVENESS OF ADALIMUMAB IN CROHN’S DISEASE: OBSERVATIONAL DATA FROM THE PYRAMID REGISTRY

Edward Loftus, Geert R. D'Haens, Walter Reinisch, Jack Satsangi, Remo Panaccione, Roopal B Thakkar, Samantha Eichner, Majin M. Castillo, Natalia Kan-Dobrosky, Martha Skup, Parvez Mulani, Jingdong Chao

Item 1 - 5 / 32
1
2 3 4